• N/A
    Market Cap
  • -89.29%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 22
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.

Fifty 1 Labs Inc. has signed a Letter of Intent to acquire BioSpark AI Technologies Inc., a Vancouver-based AI company specializing in clinical data extraction and analysis. The proposed acquisition involves 25 million common shares and aims to strengthen Fifty 1 Labs' position in AI-powered healthcare solutions.

09/30/2025, 9:56 AM • Benzinga

Peers

Statistics

More
Day Range
$0.0003
$0.0004
$0.0003
1-Year Range
$0.0002
$0.004
$0.0003
Latest Close$0.0003
Change
$0.00 (0.00%)
Volume3,278,780

Information as of 08/21/2026

Company Profile

Fifty 1 Labs, Inc.
https://fifty1labs.com
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
751 North Drive, Melbourne, FL, United States, 32934
877 814 4188

Fifty 1 Labs, Inc. operates as a retailer in the used vehicle market of the United States. It focuses primarily on the buy here/pay here segment of the independent used vehicle sales and finance market. The company sells approximately 2000 and newer model-year used vehicles and provides related financing through sale type leases. As of December 31, 2010, it had two retail locations in Arizona. Fifty 1 Labs, Inc. was formerly known as Consumer Automotive Finance, Inc. and changed its name to Fifty 1 Labs, Inc. in March 2025. Fifty 1 Labs, Inc. was incorporated in 1998 and is based in Melbourne, Florida.

Key Executives

  • Alind Gupta
  • Nima Sakian
  • Brandon Spikes
  • Martin Mills
  • Richard Robins

Current Ownership Distribution

  • Other571.9M (100.00%)
  • Insiders9,500 (0.002%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)